Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
Abstract Osteosarcoma (OS) pulmonary metastasis translates into poor patient survival. The implication of PD‐1‐PD‐L1 pathway in the context of NK cells and/or macrophages in OS is unknown. We investigated the effect of anti‐PD‐1 in OS lung metastasis and the role of NK cells and/or macrophages in an...
Saved in:
Main Authors: | Pooja Dhupkar, Nancy Gordon, John Stewart, Eugenie S. Kleinerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-06-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1518 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
by: T. N. Sotnikova, et al.
Published: (2023-07-01) -
Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
by: Waluyo Sugito, et al.
Published: (2022-04-01) -
(η4-Trimethylenemethane)(1,1,1-tris{[bis(4-methoxyphenyl)phosphanyl]methyl}ethane)ruthenium(II) diethyl ether hemisolvate
by: Carolin A. M. Stein, et al.
Published: (2025-06-01) -
Effect of cabozantinib in patients with advanced osteosarcoma: A single-center retrospective study
by: Huyan Su, et al.
Published: (2025-07-01) -
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
by: Liujing Qu, et al.
Published: (2024-07-01)